Search results for "Mechanism"

showing 10 items of 1835 documents

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease

2001

Cholinesterase inhibitors are the only approved drug treatment for patients with mild to moderately severe Alzheimer's disease. Interestingly, the clinical potency of these drugs does not correlate well with their activity as cholinesterase inhibitors, nor is their action as short lived as would be expected from purely symptomatic treatment. A few cholinesterase inhibitors, including galantamine, produce beneficial effects even after drug treatment has been terminated. These effects assume modes of action other than mere esterase inhibition and are capable of inducing systemic changes. We have recently discovered a mechanism that could account, at least in part, for the above-mentioned unex…

medicine.medical_specialtyPatch-Clamp TechniquesReceptors NicotinicPharmacologyCell LineMiceAllosteric RegulationAlzheimer DiseaseInternal medicinemedicineGalantamineAnimalsHumansNootropic AgentsBiological PsychiatryCholinesteraseAcetylcholine receptorNeuronsbiologyGalantamineChemistryNicotinic acetylcholine receptorNicotinic agonistEndocrinologyMechanism of actionTacrinebiology.proteinCholinesterase Inhibitorsmedicine.symptomAllosteric SiteAcetylcholinemedicine.drugBiological Psychiatry
researchProduct

Pathologist’s Findings after PTCA (The Mechanism of Angioplasty)

1991

Knowledge of the pathological changes induced by percutaneous transluminal coronary angioplasty (PTCA) is necessary to understand its complications.

medicine.medical_specialtyPercutaneous transluminal coronary angioplastybusiness.industryMechanism (biology)medicine.medical_treatmentLeft Main Coronary Artery Stenosissurgical procedures operativeAngioplastyInternal medicineCardiologyMedicinecardiovascular diseasessense organsRadiologyskin and connective tissue diseasesbusinesstherapeuticsPathological
researchProduct

The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice

2009

Oleoylethanolamide (OEA) is an endogenous lipid produced in the intestine that mediates satiety by activation of peroxisome proliferator-activated receptor alpha (PPARalpha). OEA inhibits gastric emptying and intestinal motility, but the mechanism of action remains to be determined. We investigated whether OEA inhibits intestinal motility by activation of PPARalpha. PPARalpha immunoreactivity was examined in whole mount preparations of mouse gastrointestinal (GI) tract. The effect of OEA on motility was assessed in wildtype, PPARalpha, cannabinoid CB(1) receptor and CB(2) receptor gene-deficient mice and in a model of accelerated GI transit. In addition, the effect of OEA on motility was as…

medicine.medical_specialtyPhysiologymedicine.medical_treatmentTRPV Cation ChannelsMotilityOleic AcidsBiologydigestive systemReceptor Cannabinoid CB2MiceOleoylethanolamidechemistry.chemical_compoundReceptor Cannabinoid CB1Glucagon-Like Peptide 1Internal medicinemedicineAnimalsPPAR alphaReceptorMice KnockoutGastric emptyingEndocrine and Autonomic Systemsdigestive oral and skin physiologyGastroenterologyImmunohistochemistryEndocannabinoid systemEndocrinologyMechanism of actionchemistrylipids (amino acids peptides and proteins)CannabinoidPeroxisome proliferator-activated receptor alphamedicine.symptomGastrointestinal MotilityEndocannabinoids
researchProduct

Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats

2011

Please cite this paper as: Pellicer B, Herraiz S, Cauli O, Rodrigo R, Asensi M, Cortijo J, Serra V, Morcillo E, Felipo V, Simon C, Pellicer A. Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats. BJOG 2011;118:615–623. Objective  To determine the effects of chronic administration of sildenafil citrateon healthy pregnant rats. Design In vivo animal experimental study. Setting  Fundacion IVI–Instituto Universitario IVI, Valencia, Spain. Sample  Pregnant and non-pregnant Wistarrats exposed to chronic administration of sildenafil. Methods  Placental cross-barrier and feto-maternal relationship levels, maternal blood pressure, and haemody…

medicine.medical_specialtyPregnancyFetusmedicine.drug_mechanism_of_actionSildenafilbusiness.industryBlood viscosityObstetrics and Gynecologymedicine.diseasechemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryInternal medicinecardiovascular systemmedicineVascular resistanceGestationbusinessPhosphodiesterase 5 inhibitorDuctus venosusBJOG: An International Journal of Obstetrics & Gynaecology
researchProduct

Mechanism of New Antipsychotic Medications

2003

Antagonism of D 2 -like dopamine receptors is the putative mechanism underlying the antipsychotic efficacy of psychotropic drugs. Positron emission tomographic studies suggest that the antipsychotic effect of dopamine receptor antagonists occurs within a therapeutic window between 60% and 80%(striatal) D 2 receptor occupancy. The incidence of extrapyramidal side effects increases above the 80% threshold. However, the novel atypical antipsychotic drug, aripiprazole, occupies up to 95% of striatal D 2 -like dopamine receptors at clinical doses, and the incidence of extrapyramidal side effects with aripiprazole is no higher than with placebo. The most likely explanation for this finding is ari…

medicine.medical_specialtyPsychosismedicine.drug_classmedicine.medical_treatmentAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistPiperazinesBasal Ganglia DiseasesArts and Humanities (miscellaneous)Dopamine receptor D2Internal medicinemedicineHumansAntipsychoticDose-Response Relationship DrugReceptors Dopamine D2Putamenmedicine.diseaseCorpus StriatumProlactinDopamine D2 Receptor AntagonistsPsychiatry and Mental healthEndocrinologyMechanism of actionDopamine receptorSchizophreniaAripiprazolemedicine.symptomPsychologyAntipsychotic AgentsTomography Emission-Computedmedicine.drugArchives of General Psychiatry
researchProduct

Psychoanalytically-Oriented Inpatient Psychotherapy of Somatoform Disorders

2008

Somatoform disorders have been neglected in psychoanalytic publications. Unlike the descriptive approach of DSM-IV and ICD-10, sophisticated psychoanalytical models have been proposed for many years explaining the development of physical symptoms without definable medical cause. Based on a review of the psychoanalytic models of somatization and conversion, this article explores difficulties in the medical and psychotherapeutic treatments of somatoform disorders. The unique tradition of psychosomatic inpatient treatment in Germany is illustrated by the psychoanalytic treatment setting at the University of Mainz. A case report of a somatoform patient shows how childhood trauma is activated an…

medicine.medical_specialtyPsychotherapistmedicine.medical_treatmentArt therapyModels PsychologicalGroup psychotherapyGermanymedicineHumansPsychoanalytic theorySomatoform DisordersPsychiatryAgedDefense MechanismsDance TherapySocial environmentMultimodal therapyGeneral Medicinemedicine.diseasePsychoanalytic TherapyHospitalizationPsychiatry and Mental healthClinical PsychologyMentalizationChronic DiseaseWorking throughFemalePsychologySomatizationThe Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
researchProduct

A common role for psychotropic medications: memory impairment.

2002

Summary The psychopathologic profile of mental disorders is very diverse and psychotropic medications used to treat them differ in their chemical structure. Nevertheless, these drugs share these four characteristics: delayed onset of clinical response, not one of them can be said to cure, there is a high number of non-responders, and the mechanism responsible for their therapeutic action is not known. It is hypothesized that the action of psychotropic medications is memory impairment, understanding memory as the trace left in the nervous system not only by individual experiences but also by genetic and epigenetic phenomena. It is suggested that it would be beneficial to translate some resea…

medicine.medical_specialtyPsychotropic DrugsTherapeutic actionMechanism (biology)Mental DisordersDelayed onsetBrainGeneral MedicineModels PsychologicalAntidepressive AgentsAction (philosophy)Research strategiesMemorymedicineCyclic AMPMemory impairmentHumansPsychologyPsychiatryClinical psychologyAntipsychotic AgentsSignal TransductionMedical hypotheses
researchProduct

PROSPECTIVE, RANDOMIZED, CROSSOVER COMPARISON OF SUBLINGUAL APOMORPHINE (3 mg) WITH ORAL SILDENAFIL (50 mg) FOR MALE ERECTILE DYSFUNCTION

2004

Abstract: Purpose: We established the efficacy and safety of sublingual apomorphine compared with oral sildenafil. in comparable groups of patients with erectile dysfunction (ED). Materials and Methods: This prospective, randomized, crossover study included 77 heterosexual men with ED of various etiologies and severities. A total of 62 men were randomized but only 34 were evaluable for efficacy and tolerability. The study started with a run-in period of 2 to 4 weeks. The first 4 weeks of treatment were followed by a washout period of 4 weeks, after which patients changed to the alternate treatment for an additional 4-week period. The sequence of the 2 treatments was established by a randomi…

medicine.medical_specialtyRandomizationmedicine.drug_mechanism_of_actionSildenafilUrologyUrologyPenis Impotence Apomorphine SildenafilSildenafil 50 MGlaw.inventionSettore MED/24 - Urologiachemistry.chemical_compoundRandomized controlled triallawmedicineProspective cohort studybusiness.industryMale erectile dysfunctionmedicine.diseaseCrossover studyrespiratory tract diseasesApomorphineErectile dysfunctionmedicine.anatomical_structureTolerabilitychemistryAnesthesiacardiovascular systemSexual functionbusinessPhosphodiesterase 5 inhibitorPenismedicine.drug
researchProduct

Response to ‘Detecting right ventricular dysfunction in patients diagnosed with low-risk pulmonary embolism: is routine computed tomographic pulmonar…

2019

medicine.medical_specialtyRivaroxabanmedicine.diagnostic_testmedicine.drug_mechanism_of_actionbusiness.industryFactor Xa Inhibitormedicine.diseaseRight ventricular dysfunctionPulmonary embolismComputed tomographicAngiographyPulmonary angiographyMedicineIn patientRadiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

An irregular atrial tachycardia : What is the underlying mechanism?

2017

medicine.medical_specialtySettore MED/09 - Medicina InternaMechanism (biology)business.industryECGP waveMEDLINE030204 cardiovascular system & hematology03 medical and health sciencesText mining0302 clinical medicineInternal medicineCardiologyMedicineIrregular tachycardia030212 general & internal medicinemedicine.symptomCardiology and Cardiovascular MedicinebusinessAtrial tachycardia
researchProduct